A detailed history of State Of Wisconsin Investment Board transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 64,176 shares of REGN stock, worth $45 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
64,176
Previous 57,434 11.74%
Holding current value
$45 Million
Previous $60.4 Million 11.76%
% of portfolio
0.18%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $6.9 Million - $8.1 Million
6,742 Added 11.74%
64,176 $67.5 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $45,043 - $54,630
51 Added 0.09%
57,434 $60.4 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $1.53 Million - $1.69 Million
1,700 Added 3.05%
57,383 $55.2 Million
Q4 2023

Feb 12, 2024

SELL
$775.18 - $881.7 $1.34 Million - $1.52 Million
-1,724 Reduced 3.0%
55,683 $48.9 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $6.19 Million - $7.55 Million
-8,939 Reduced 13.47%
57,407 $47.2 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $56,002 - $66,428
-80 Reduced 0.12%
66,346 $47.7 Million
Q1 2023

May 15, 2023

SELL
$680.49 - $826.97 $1.03 Million - $1.26 Million
-1,518 Reduced 2.23%
66,426 $54.6 Million
Q4 2022

Feb 14, 2023

SELL
$705.89 - $766.39 $1.94 Million - $2.11 Million
-2,753 Reduced 3.89%
67,944 $49 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $8.96 Million - $11.3 Million
-15,617 Reduced 18.09%
70,697 $48.7 Million
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $3.01 Million - $4.05 Million
-5,483 Reduced 5.97%
86,314 $51 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $14.9 Million - $17.5 Million
25,028 Added 37.48%
91,797 $64.1 Million
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $3 Million - $3.71 Million
-5,523 Reduced 7.64%
66,769 $42.2 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $3.82 Million - $4.54 Million
6,661 Added 10.15%
72,292 $43.8 Million
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $4.12 Million - $4.87 Million
-8,719 Reduced 11.73%
65,631 $36.7 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $4.84 Million - $5.94 Million
-10,843 Reduced 12.73%
74,350 $35.2 Million
Q4 2020

Feb 03, 2021

SELL
$478.3 - $607.98 $234,367 - $297,910
-490 Reduced 0.57%
85,193 $41.2 Million
Q3 2020

Nov 16, 2020

SELL
$544.75 - $658.21 $17.1 Million - $20.7 Million
-31,461 Reduced 26.86%
85,683 $48 Million
Q2 2020

Aug 12, 2020

BUY
$493.32 - $643.92 $35.4 Million - $46.2 Million
71,694 Added 157.74%
117,144 $73.1 Million
Q1 2020

May 06, 2020

SELL
$336.18 - $494.43 $5.16 Million - $7.58 Million
-15,336 Reduced 25.23%
45,450 $22.2 Million
Q4 2019

Feb 14, 2020

SELL
$274.13 - $376.51 $4.86 Million - $6.68 Million
-17,741 Reduced 22.59%
60,786 $22.8 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $467,616 - $544,446
1,710 Added 2.23%
78,527 $21.8 Million
Q2 2019

Aug 14, 2019

SELL
$299.6 - $414.82 $2.28 Million - $3.16 Million
-7,610 Reduced 9.01%
76,817 $24 Million
Q1 2019

May 13, 2019

SELL
$372.08 - $439.57 $1.01 Million - $1.19 Million
-2,713 Reduced 3.11%
84,427 $34.7 Million
Q4 2018

Feb 11, 2019

BUY
$335.82 - $403.04 $11.8 Million - $14.1 Million
34,990 Added 67.09%
87,140 $32.5 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $7.98 Million - $9.28 Million
-22,726 Reduced 30.35%
52,150 $21.1 Million
Q2 2018

Aug 03, 2018

BUY
$284.6 - $344.99 $625,835 - $758,633
2,199 Added 3.03%
74,876 $25.8 Million
Q1 2018

May 07, 2018

BUY
$315.82 - $393.78 $1.39 Million - $1.74 Million
4,415 Added 6.47%
72,677 $25 Million
Q4 2017

Feb 08, 2018

SELL
$358.63 - $469.95 $5.48 Million - $7.18 Million
-15,286 Reduced 18.3%
68,262 $25.7 Million
Q3 2017

Nov 01, 2017

BUY
$431.38 - $504.0 $36 Million - $42.1 Million
83,548
83,548 $37.4 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.